Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Myocardial Inflammation in Postischemic Myocardium
NCT02281305Phase 4Unknown
- Sponsor
- G. Gennimatas General Hospital
- Start
- Oct 2014
- Primary completion
- Apr 2015
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in myocardial infarction (MI) comparing Colchicine Arm with Placebo Arm (2 arms). Primary endpoint: Degree of inflammation of the involved myocardium as assessed by the PET scan at 5 days. Status: unknown.
02
Drugs
colchicine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT02281305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02281305.